Search research articles
Contact Us
Filters
Showing results (551-560 of 570) with videos related to
Page
of 57
Sort By:
Ejhaem
|
February 2, 2026
Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive Cohort
A Coste, S Godet, S Manier, et al.
Leukemia
|
July 13, 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
P Moreau, M Attal, F Garban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
G Fouquet, B Pegourie, M Macro, et al.
British Journal of Haematology
|
May 15, 2024
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry
B Ferment, J Lambert, D Caillot, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
The EMBO Journal
|
May 25, 2021
Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters
Gamma Chi, Rebecca Ebenhoch, Henry Man, et al.
Nature Communications
|
March 6, 2024
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma
C Grandclément, C Estoppey, E Dheilly, et al.
Leukemia
|
December 19, 2017
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
H Ludwig, M Delforge, T Facon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2025
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
P Musto, M Engelhardt, N W C J van de Donk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Page
of 57
Search research articles
Search
Showing results (551-560 of 570) with videos related to
Sort By:
Page
of 57
Ejhaem
|
February 2, 2026
Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive Cohort
A Coste, S Godet, S Manier, et al.
Leukemia
|
July 13, 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
P Moreau, M Attal, F Garban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
G Fouquet, B Pegourie, M Macro, et al.
British Journal of Haematology
|
May 15, 2024
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry
B Ferment, J Lambert, D Caillot, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
The EMBO Journal
|
May 25, 2021
Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters
Gamma Chi, Rebecca Ebenhoch, Henry Man, et al.
Nature Communications
|
March 6, 2024
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma
C Grandclément, C Estoppey, E Dheilly, et al.
Leukemia
|
December 19, 2017
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
H Ludwig, M Delforge, T Facon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2025
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
P Musto, M Engelhardt, N W C J van de Donk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Page
of 57